Lagevrio
NDC Package 0006-5055-09

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Lagevrio is no contraindications have been identified based on the limited available data on the emergency use of molnupiravir authorized under this EUA. Marketed by Merck Sharp & Dohme Llc, this product is identified by NDC 0006-5055.

Identification & Billing

NDC Package Code
0006-5055-09
Package Description
40 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
0006-5055
11-Digit Billing Format
00006505509
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lagevrio
Dosage Form
-
Usage Information
No contraindications have been identified based on the limited available data on the emergency use of molnupiravir authorized under this EUA.

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Llc
Marketing Category
EMERGENCY USE AUTHORIZATION -
Start Marketing Date
12-23-2021
Listing Expiration
12-31-2026
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0006-5055). Click a package code to view its specific billing and regulatory data.

0006-5055-06
40 CAPSULE in 1 BOTTLE, PLASTIC
0006-5055-07
40 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0006-5055-09 identifies a specific commercial package of 40 capsule in 1 bottle, plastic of Lagevrio, labeled by Merck Sharp & Dohme Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Llc on December 23, 2021. The current certification is valid through December 31, 2026.

How is this Merck Sharp & Dohme Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00006505509. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0006-5055-09
11-Digit CMS (5-4-2)
00006-5055-09

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.